Sugi Predict

Sugi Predict / Compounds / SCHEMBL711474

SCHEMBL711474

SCHEMBL711474

CC(C)Oc1ccc(NC(=O)[C@@H]2CCC[C@@H](S(=O)(=O)c3ccccn3)C2)nc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 5/20 0.46
▸ RAB9A P51151 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ ELOVL6 Q9H5J4 1/20 0.44
▸ PKM P14618 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ DEGS1 O15121 1/20 0.40
▸ LMNA P02545 1/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ NPY5R Q15761 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851423 1.00 ABL1 (0.46) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2851400 0.91 ABL1 (0.52) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL710662 0.91 ABL1 (0.52) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2849284 0.89 ABL1 (0.46) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2849286 0.89 ABL1 (0.46) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2852312 0.88 ELOVL6 (0.56) RAB9ANPC1ALDH1A1SMN1; SMN2ELOVL6
SCHEMBL2852237 0.88 ABL1 (0.48) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2852234 0.88 ABL1 (0.48) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL2852313 0.88 ELOVL6 (0.56) RAB9ANPC1ALDH1A1SMN1; SMN2ELOVL6
SCHEMBL2849781 0.85 ABL1 (0.48) ABL1RAB9ANPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2236494-B1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD KK (JP) 2016-08-31 — — EP claimed
US-8124807-B2 Sulfonyl-substituted 6-membered ring derivative MSD K.K. (JP) 2012-02-28 — — US claimed
EP-2236494-A1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-10-06 — — EP claimed
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD K.K. (JP) 2010-09-30 — — US claimed
EP-2236494-B1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD KK (JP) 2016-08-31 — — EP disclosed
US-8124807-B2 Sulfonyl-substituted 6-membered ring derivative MSD K.K. (JP) 2012-02-28 — — US disclosed
US-8124807-B2 Sulfonyl-substituted 6-membered ring derivative MSD K.K. (JP) 2012-02-28 — — US disclosed
EP-2236494-A1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-10-06 — — EP disclosed
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD K.K. (JP) 2010-09-30 — — US disclosed
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD K.K. (JP) 2010-09-30 — — US disclosed
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD K.K. (JP) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE CHRM2, CHRM3, CHRM1 ABL1 3478/4885RAB9A 2414/4885NPC1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.